Publication | Open Access
Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor
76
Citations
35
References
2021
Year
Medicinal ChemistryParp InhibitorPharmaceutical ChemistryCdk12-cyclin KMedicineNatural SciencesSynthetic LethalityAnti-cancer AgentChemical BiologyPharmacologyCell BiologyCell SignalingNovel TherapyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1